Ms. Tenaerts was a panelist for the Forum’s discussion on Drug Trials and The 21st Century Cures Act.
Pamela Tenaerts works closely with the CTTI Executive Committee to develop and implement strategies to accomplish CTTI’s mission. She provides senior level oversight of the day-to-day operations of CTTI and orchestrates efforts to effectively engage all interested stakeholders to improve the conduct of clinical trials.
With more than 20 years’ experience in the conduct of clinical trials across a number of sectors, she practiced medicine in both the emergency department and private practice setting for several years before embarking on a career in research. She served as the European coordinator for a 41,000 patient Phase III study of thrombolytic therapy at the University of Leuven, and later as the North American coordinator for an international Phase II study of anti-thrombin therapy at Duke University Medical Center. She then accepted a position at Sarasota Memorial Hospital, where she directed a multi-specialty centralized clinical trials office for over ten years. Most recently Dr. Tenaerts oversaw European operations for CoAxia, a medical device company focused on cerebral ischemia. She received her MD from Catholic University of Leuven, Belgium, and a MBA from the University of South Florida. She speaks five languages and has obtained Six Sigma Green Belt certification.